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ABSTRACT
 ىلع ةيديلقتلا ةقيرطلاب ةثللا جلاع ريثأت نم ققحتلا   :فادهلأا
 ةمعادلا ةجسنلأا ةلاح ىلعو ،يساكترلإا يس ينتورب تايوتسم
 نزولا  تاوذ  ءاسنلاو  ةنمسلاب  تاباصلما  ءاسنلا  ىدل  نانسلأل
.نمزلما ةثللا باهتلاب تاباصلماو يعيبطلا
 ةيلك  يف  ةنراقلما  ةيريرسلا  ةساردلا  هذه  تيرجُأ   :ةقيرطلا
 ةيبرعلا  ةكلملما  ،ةدج  ،زيزعلادبع  كللما  ةعماج  ،نانسلأا
 سرام  ىلإ  م2009  ربمسيد  نم  ةرتفلا  للاخ  كلذو  ةيدوعسلا
 طسوتلما ةثللا باهتلاب ةباصم ةديس 40 ةساردلا تلمش .م2011
 ةباصم  ةديس  20  :امهو  ينتعومجم  ىلإ  نمسُق  دقو  ،دالحا  ىلإ
 نزولا  تاوذ  نم  ةديس  20و  ،)ةساردلا  ةعومجم(  ةنمسلاب
 ءاسنلا  ءانثتساب  انمق  دقلو  .)دهاشلا  ةعومجم(  يعيبطلا
 انمق  دقو  .ةيزاهلجا  ضارملأاب  تاباصلماو  ،لماولحاو  ،تانخدلما
 نيرهشب  جلاعلا  دعبو  لبق  ةيلاتلا  سيياقلما  تايوتسم  ليلحتب
 طابترلاا  ىوتسمو  ،يساكترلإا  يس  ينتورب  تايوتسم  :يهو
.ةثللا نم فيزنلا تاجردو ،ربسلا قمعو ،يريرسلا
 تاباهتللاا تايوتسم ليلقت يف ًلااعف ةثللا جلاع ناك دقل  :جئاتنلا
 ةنيع لماك يف يساكترلإا يس ينتورب تايوتسم ليلقتو ،ةيوثللا
 ىوتسم نأ ىلإ جئاتنلا تراشأو .ينتعومجلما يتلك يفو ةساردلا
 تلصو اميف ،)±0.51( 0.78 جلاعلا لبق ناك دق ينتوربلا اذه
 عومجم يف رتل/غلم )±0.41( 0.55 ىلإ جلاعلا دعب هتايوتسم
 يف جلاعلل ةباجتسلاا ىدم نأ ًاضيأ ظحولو .)p=0.001( ةنيعلا
 نأ ريغ ،ةساردلا ةعومجم نم نسحأ ناك دق دهاشلا ةعومجم
 طسوتم غلب ثيح ةيئاصحلإا ةيحانلا نم ًاريبك نكي مل قرفلا اذه
 )±0.43(  0.28  يساكترلإا  يس  ينتورب  تايوتسم  يف  ريغتلا
.رتل/غلم )±0.32( 0.19و
 ليلقت  يف  ةثللا  جلاع  ةيلاعف  ىدم  ةساردلا  ترهظأ   :ةتماخ
 نكي مل امك ،يساكترلإا يس ينتورب تايوتسم ليلقتو باهتللاا
 .جلاعلا اذهل ةباجتسلاا ىدم ىلع يبلس ريثأت يأ ةنمسلل
Objectives: To investigate the effect of conventional 
periodontal therapy on serum C-reactive protein 
)CRP( level and periodontal status in obese and 
normal-weight chronic periodontitis patients. 
Methods: This is a controlled clinical trial conducted 
at the King Abdulaziz University Faculty of Dentistry, 
Jeddah, Kingdom of Saudi Arabia between December 
2009 and March 2011. A total of 40 women affected 
with moderate to severe chronic periodontitis were 
selected )20 obese [test group] and 20 normal-weight 
[control](. Smokers, pregnant women, and subjects 
with any systemic disease were excluded. Serum CRP 
level and periodontal parameters, including clinical 
attachment level, probing depth, bleeding on probing 
and plaque scores were assessed at baseline, and 2 
months after non-surgical periodontal treatment.
Results: Periodontal therapy was effective in reducing 
gingival inflammation, as well as serum CRP level 
in the total sample and within each group. The pre-
treatment mean level of serum CRP was 0.78 )±0.51( 
and post- treatment was 0.55 )±0.41( mg/l in the total 
sample )p=0.001(. A tendency was observed toward 
a better systemic response to treatment in normal-
weight compared to obese women, however, it was 
not statistically significant )the mean changes in 
CRP levels after therapy were 0.28 [±0.43] and 0.19 
[±0.32] mg/l(. 
Conclusion: Periodontal treatment is effective in 
reducing systemic inflammation as measured by 
serum CRP level, and obesity does not have a major 
negative impact on response to periodontal therapy.
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Periodontitis, a common chronic disease caused primarily by bacterial infection, destroys the soft 
tissues and bone that support the teeth and ultimately 
may lead to tooth loss if not treated.1 Periodontitis 
affects the majority of adult population worldwide, and 
in Saudi Arabia it was reported to affect 72%.2,3  Recent 
evidences suggest that periodontal infection might 
also influence individuals’ overall health by acting 
as an aggravating factor to systemic inflammation 
where serum levels of several inflammatory markers 
in periodontitis patients were significantly elevated 
compared to healthy controls.4-8 Periodontal infection 
is implicated as a possible risk factor for cardiovascular 
diseases, adverse pregnancy outcome, and poor glycemic 
control in diabetics.9-16 It has been shown that individuals 
with periodontitis are more prone to cardiovascular 
diseases than periodontally healthy individuals.10,11 
Pregnant women who were affected with periodontitis 
were found to be more likely to deliver preterm low 
birth weight babies when compared to periodontally 
healthy pregnant women.12 Severe periodontal infection 
was also found to aggravate the risk of poor glycemic 
control in patients with type 2 diabetes.13 Furthermore, 
treatment of periodontitis with scaling and root planing 
was suggested to reduce level of inflammatory markers 
such as serum C-reactive protein )CRP( level.14-16 C-
reactive protein is implicated in the pathogenesis of 
several chronic conditions including cardiovascular 
diseases.17
Individuals are not alike in their susceptibility to 
periodontitis as certain environmental and systemic 
factors )such as smoking and diabetes( increase the risk 
for developing periodontitis.2 Obesity has recently been 
suggested as a possible risk factor for periodontitis.18-22 
In one study, it was considered to be the second strongest 
risk factor for periodontitis preceded only by smoking.22 
The biological mechanism by which obesity may 
predispose to periodontitis is not totally understood. A 
probable mechanism is through increasing secretion of 
certain proinflammatory cytokines that are known to 
be associated with destruction of periodontal tissues, 
such as interleukin-6 )IL-6( and tumor necrosis factor-
alpha )TNF-α(.19 Several proinflammatory molecules, 
including TNF-α and IL-6, have been shown to be 
synthesized and secreted by adipose tissue.23-25 Both 
TNF-α and IL-6 induce acute-phase hepatic protein 
production such as CRP.26 They might also impair 
intracellular insulin signaling, and subsequently may 
lead to insulin resistance.23,27 Elevated plasma levels of 
TNF-α, IL-6, and CRP are associated with obesity and 
insulin resistance.24,27 Insulin resistance has recently 
been suggested to explain the association between 
obesity and periodontitis.28 Although obesity might 
contribute to the development of periodontitis, little 
is known about the effect of obesity on the outcome 
of periodontal treatment.29 The objectives of this study 
were to examine the effect of periodontal treatment on 
serum level of CRP in patients affected with moderate 
/severe periodontitis and to determine if the response to 
periodontal therapy differs between obese and normal-
weight chronic periodontitis patients.
Methods.	 Study population and design. The 
sample for the present study was recruited from an 
adult patient population who attended the Faculty of 
Dentistry clinics at King Abdulaziz University )KAU(, 
Jeddah, Kingdom of Saudi Arabia between December 
2009 and March 2011.  Since the prevalence of smoking 
among male patients affected with periodontitis is high, 
only female patients were recruited. The study was 
conducted in full accordance with the principles of 
Helsinki Declaration and was reviewed and approved by 
Deanship of Scientific Research at KAU. An informed 
consent was obtained from each participant prior to 
their enrollment in the study. 
Female patients, 35 years of age or older who suffer 
from generalized moderate/severe chronic periodontitis, 
and have at least 20 teeth were asked to participate. 
Classification of periodontitis was made according to 
the criteria of the American Academy of Periodontology 
International Workshop for Classification of Periodontal 
Diseases.30 Specifically, individuals were considered to 
have generalized moderate/severe chronic periodontitis 
if they had  ≥3mm of clinical attachment loss at ≥30 of 
the sites.  Those with any of the following criteria were 
excluded: )1( presence of systemic diseases or infection, 
)2( periodontal therapy in the previous 12 months 
)3( systemic antibiotic use in the previous 3 months, 
)4( pregnancy or lactation, )5( smokers, and )6( those 
who require antibiotic prophylaxis before periodontal 
treatment. A total of 40 consecutive female patients, 
20 obese and 20 normal-weights were included. A 
full mouth periodontal examination, excluding third 
molars and partially erupted teeth, was performed for 
Disclosure. This study was supported by a grant from 
Deanship of Scientific Research at King Abdulaziz 
University, Jeddah, Kingdom of Saudi Arabia )Grant 
No. 9/20/429(. Authors have no conflict of interests, 
and the work was not supported or funded by any drug 
company.
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each participant by a single calibrated examiner who 
achieved a 93% intra-examiner reliability in detecting 
probing depth within 1mm. Intra-examiner reliability 
was calculated by comparing 2 measurements performed 
on 5 chronic periodontitis patients not related to the 
study.  Blood samples were obtained and stored for 
measurement of CRP. Then, periodontal treatment 
consisting of oral hygiene instruction and scaling and 
root planing were performed by one operator. Another 
full mouth periodontal examination and blood sample 
collection was performed to all participants after 2 
months. 
Study variables. Weight in kilograms and height in 
meters were measured. Body mass index )BMI(, was 
then computed from weight in kilograms divided by 
the square height in meters.  Obese subjects were those 
with BMI of ≥30 kg/m2 and normal-weight with 18.50 
to <25 kg/m2. Socio-demographics and periodontitis 
risk factors were obtained from all participants. 
Periodontal assessment was undertaken by recording the 
following clinical parameters at 6 sites per each tooth: 
probing depth )PD(, gingival recession )GR(, clinical 
attachment level )CAL(, bleeding on probing )BOP(, 
and plaque scores )PS(. Probing depth was recorded in 
mm using a manual periodontal probe as the distance 
from the free gingival margin )FGM( to the bottom 
of the sulcus/pocket. Whereas, the distance from the 
cemento-enamel junction to the FGM represented 
GR. Clinical attachment level was calculated from the 
measurements of GR and PD. Bleeding on probing 
was recorded by visual observation of the presence of 
bleeding )yes or no( after a site has been probed for a 
pocket depth measurement and then the percentage 
of sites with BOP for each patient was calculated. 
Presence of plaque deposits was recorded as yes or no 
prior to the assessment of probing depth and then the 
percentage of sites with plaque deposits for each patient 
was calculated.
To assess serum CRP level, blood samples were drawn 
at baseline and at 2 months after treatment. The samples 
were then coded so that the technician conducting 
laboratory assay was blinded to subjects’ identity and 
study sequence. Blood samples were immediately stored 
at -80°C. Samples were processed by an experienced 
technician using the Enzyme Linked-Immuno- Sorbent 
Assay )ELISA( for quantification of serum CRP levels.  
Statistical analysis. Descriptive statistics and 
distribution of the continuous variables were conducted 
to explore the data. Socio-demographics, periodontal 
parameters, and CRP were compared between the 
test and control group at baseline using independent 
sample t-test. The difference in the mean values of 
periodontal parameters and serum CRP, between 
baseline and 2 months post-treatment, were compared 
between the test and control group using independent 
sample t-test. Within each group the mean values at 
baseline and at 2 months were compared using paired 
t-test. All the statistical tests were 2 tailed and p-value 
<0.05 was considered statistically significant. Sample 
size calculation was conducted using standalone power 
analysis statistical program )G*Power 3.1.3, Kiel, 
Germany(. A sample size of 17 subjects per group was 
needed in order to detect an effect size )delta( of one in 
the study parameters at an alpha level of 0.05 with 80% 
power. 
Results.	The mean age of study sample was 43.7 
)±8( years. The mean age was not significantly different 
between obese )mean age, 44 [±8.4]( and normal-weight 
group )mean age, 43.4 [±7.8](, )p=0.80(. Periodontal 
parameters were not significantly different between the 
Table	1	- Clinical periodontal parameters and C-reactive protein at 
baseline in obese and normal-weight women included in this 
study at the Faculty of Dentistry clinics at King Abdulaziz 







Clinical attachment level )mm( 3.37±0.80 2.95±0.76 0.093
Probing depth )mm( 2.70±0.48 2.60±0.46 0.527
Probing depth ≥5 mm )%( 6.90±8.49 6.40±8.09 0.850
Plaque score )%( 70.44±24.49 57.37±23.33 0.097
Bleeding on probing )%( 81.29±18.95 74.83±23.16 0.346
C-reactive protein )mg/l( 0.96±0.41 0.60±0.56 0.025
Data are expressed as mean±standard deviation
Table	2	-	The effect of periodontal treatment on the clinical periodontal 
parameters and C-reactive protein in the total sample )n=40( 
of women in a study at the Faculty of Dentistry clinics at 
King Abdulaziz University )KAU(, Jeddah, Kingdom of Saudi 
Arabia.
Parameters Pre-treatment 8 weeks 
post-treatment
P-value
Clinical attachment level )mm(   3.16±0.80   2.88±0.67 0.002
Probing depth )mm(   2.65±0.47   2.44±0.41 0.001
Probing depth ≥5 mm )%(   6.65±8.19   3.08±3.58 0.002
Plaque score )%( 74.25±4.86 45.11±5.01 0.001
Bleeding on probing )%(   66.39±22.69   34.45±15.70 0.001
C-reactive protein )mg/l(   0.78±0.51   0.55±0.41 0.001
Data are expressed as mean±standard deviation
312
Effect of periodontal treatment on serum CRP level … Al-Zahrani & AlGhamdi
Saudi Med J 2012; Vol. 33 )3(     www.smj.org.sa
2 groups at baseline; whereas, CRP was significantly 
higher in the obese group )Table 1(. The mean CRP was 
0.96 )±0.41( mg/l in the obese versus 0.60 )±0.56( mg/l 
in the normal-weight group, )p=0.025(. There was also 
a trend toward a better periodontal health among 
normal-weight as compared to the obese women. The 
mean clinical attachment loss was 3.4 )±0.8( mm 
among the obese versus 2.95 )±0.76( mm among the 
normal-weight )p=0.09(. After periodontal treatment, 
there was a significant decrease in all clinical periodontal 
parameters as well as CRP level in the total sample and 
within each group as shown in Table 2 and Figure 1. 
Although the decrease in CRP level in normal-weight 
group was greater than that in the obese group; the 
difference between groups was no statistically significant 
)p=0.48( as shown in Table 3. 
Discussion.	In the present study, the effect 
of periodontal therapy on serum CRP level and 
periodontal status in obese and normal-weight women 
affected with chronic periodontitis was studied. The 
results showed that periodontal therapy is effective 
in reducing gingival inflammation as well as serum 
CRP level in the total sample and within each group. 
These results are consistent with previous studies that 
showed a decrease in CRP level after treatment of 
periodontitis with scaling and root planing.14,15,31-33 In 
contrast, other studies did not show a change in CRP 
level after periodontal therapy.34,35 The variability in 
the results among different studies could be attributed 
to differences in baseline values of inflammatory 
markers, characteristics and susceptibility of the studied 
population, and periodontitis severity.The time interval 
between periodontal treatment and blood collection for 
CRP level assessment varies among different studies. 
Ide et al34 found no reduction in CRP level 6 weeks 
after periodontal treatment whereas Mattila et al33 
observed a reduction in CRP levels at 6-week post-
treatment. Iwamoto et al15 collected blood 4 weeks post-
periodontal therapy and reported a significant reduction 
in CRP, whereas Elter et al36 reported a trend but no 
significant reduction in serum levels of CRP during the 
4-week interval. In other studies, a significant reduction 
in CRP was only found 6 months after periodontal 
treatment.31,32 In the present study, evaluation of 
response to periodontal therapy and the assessment of 
CRP level post-treatment were undertaken 2 months 
post-treatment. The choice of the 2 months follow up is 
based on the conclusion from a previous critical review 
of the literature.37
The observed decrease in the CRP level after 
periodontal therapy in the present study is probably 
due to the marked reduction in the infection burden. 
Periodontitis is primarily caused by Gram-negative 
bacteria that are part of the plaque biofilm deposited 
on the teeth.1 These periodontal pathogens are involved 
in aggravating systemic inflammation and immune 
response in addition to their role in increasing gingival 
inflammation and destruction of periodontal tissue. 
Periodontal therapy is effective in reducing local 
inflammation and improving the periodontal clinical 
parameters by reducing bacterial load in periodontal 
pockets and improving the antibody titers and avidity 
to periodontal pathogens. This in turn may decrease the 
infection burden and systemic inflammation. 
Table	3	-	Mean differences in periodontal parameters and C-reactive 
protein between pre- and post-periodontal therapy in obese and 
normal-weight women included in this study at the Faculty of 
Dentistry clinics at King Abdulaziz University )KAU(, Jeddah, 









Clinical attachment level )mm( 0.29 ±0.53 0.27±0.57 0.938
Probing depth )mm( 0.23±0.33 0.19±0.27 0.663
Probing depth ≥5 mm )%( 3.85±6.89 3.30±6.94 0.803
Plaque score )%( 32.97±18.42 13.83±4.64 0.105
Bleeding on probing )%( 34.88±18.47 20.20±5.52 0.207
C-reactive protein )mg/l( 0.19±0.32 0.28±0.43 0.480
Data are expressed as mean ±SD
Figure	1	- The mean C-reactive protein level )CRP( )mg/l( before and 
after periodontal treatment in obese and normal-weight 
women included in this study at the Faculty of Dentistry 
clinics at King Abdulaziz University )KAU(, Jeddah, Kingdom 
of Saudi Arabia.
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The findings of the present study showed a trend 
toward a better systemic response to periodontal 
therapy in normal-weight compared to obese women; 
the difference however, was not statistically significant. 
These findings support the results of a recent study in 
which obesity was not found to negatively interfere with 
the improvement in the periodontal clinical parameters 
or the decrease in the circulating proinflammatory 
cytokine levels after periodontal treatment.29 In the 
present study, the definition of obesity was based on 
the body mass index )BMI( which is highly associated 
with fat mass and morbidity and mortality.38 Although 
BMI adequately predicts obesity-related disease risk in 
most populations, it has some limitations. For example, 
the BMI does not consider body fat distribution and 
therefore does not differentiate between abdominal and 
general obesity. Abdominal obesity is associated with a 
higher morbidity than general obesity.39 Future studies 
that include other measures of obesity such as waist 
circumference are warranted. The periodontal therapy 
in the present study consisted of the common initial 
treatment of periodontitis in clinical practice, namely, 
oral hygiene instructions and removal of bacterial plaque 
and calculus deposits from the tooth surfaces. Although 
this therapy has resulted in a marked improvement 
in periodontal status, periodontal inflammation was 
not completely eliminated. Response to other forms 
of periodontal treatment such as surgical periodontal 
therapy might show different results from the one 
observed in the present study. 
Study limitation. It has to be noted that this study 
included only women; therefore, it does not provide 
evidence on the effect of non-surgical periodontal 
therapy in obese men.
In conclusion, the results of the present study 
confirm the effect of periodontal therapy on reducing 
systemic inflammation in both obese and normal-weight 
women. Further studies need to assess the effect of 
surgical periodontal therapy on CRP and other systemic 
inflammatory markers such as TNF-α and IL-6 in obese 
individuals. As periodontitis is a common infectious 
disease in Saudi Arabia, prevention and management 
of periodontal infection might have a substantial health 
implication. Furthermore, health care providers need to 
consider periodontal infection as a potential reason for 
increasing level of serum CRP. 
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